Erasca (ERAS) Change in Acquisitions & Divestments (2020 - 2026)

Erasca (ERAS) posted Change in Acquisitions & Divestments of $58.6 million for Q1 2026, down 12.55% on a QoQ basis from $67.0 million in Q4 2025, and up 30.11% year-over-year from $45.0 million in Q1 2025.

Erasca (ERAS) Change in Acquisitions & Divestments (2020 - 2026) Analysis & Trends

Erasca's Change in Acquisitions & Divestments history runs 7 years deep, the most recent figure standing at $58.6 million for Q1 2026.

  • Quarterly Change in Acquisitions & Divestments rose 30.11% year-over-year to $58.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $274.6 million (up 5.47% YoY) and the FY2025 annual result came in at $261.0 million, down 3.08% from the prior year.
  • Change in Acquisitions & Divestments was $58.6 million for Q1 2026 at Erasca, down from $67.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $89.8 million in Q4 2024 and bottomed at $7.9 million in Q2 2022.
  • A 5-year average of $53.7 million and a median of $58.6 million in 2026 frame the typical range for Change in Acquisitions & Divestments.
  • Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments sank 47.19% — and 2023, when it jumped 744.94%.
  • Erasca's Change in Acquisitions & Divestments stood at $33.9 million in 2022, then surged by 93.94% to $65.7 million in 2023, then soared by 36.51% to $89.8 million in 2024, then dropped by 25.4% to $67.0 million in 2025, then retreated by 12.55% to $58.6 million in 2026.
  • Business Quant data shows ERAS's Change in Acquisitions & Divestments at $58.6 million in Q1 2026, $67.0 million in Q4 2025, and $71.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 65,719.23 Bn 65,718.94 Bn -
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 470.97 Bn 466.18 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.29 Bn 115.05 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.98 Bn 61.22 Bn 3.31 Bn
7 Belite Bio 62.06 Bn 62.06 Bn -
8 Argenx Se 55.78 Bn 50.60 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.43 Bn 34.42 Bn 959.66 Mn
10 Erasca 5.82 Bn 5.57 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 58.55 Mn
Mar 31, 2026 58.55 Mn
Dec 31, 2025 66.95 Mn
Dec 31, 2025 66.95 Mn
Sep 30, 2025 71.25 Mn
Sep 30, 2025 71.25 Mn
Jun 30, 2025 77.83 Mn
Jun 30, 2025 77.83 Mn
Mar 31, 2025 45.00 Mn
Mar 31, 2025 45.00 Mn
Dec 31, 2024 89.75 Mn
Dec 31, 2024 89.75 Mn
Sep 30, 2024 89.33 Mn
Sep 30, 2024 89.33 Mn
Jun 30, 2024 36.25 Mn
Jun 30, 2024 36.25 Mn
Mar 31, 2024 54.00 Mn
Mar 31, 2024 54.00 Mn
Dec 31, 2023 65.75 Mn
Dec 31, 2023 65.75 Mn